Basics Exagen Inc. IPO Date: September 20, 2019 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $212.78M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.77% Avg Daily Range (30 D): $0.16 | 1.78% Avg Daily Range (90 D): $0.19 | 2.60% Institutional Daily Volume Avg Daily Volume: .05M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 104 Avg Trade Size (Sh.) (30 D): 106 Avg Trade Size (Sh.) (90 D): 120 Institutional Trades Total Inst.Trades: 64 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $4.19M Avg Inst. Trade (90 D): $2M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.93M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $.78M Avg Closing Volume: 163.1K     News Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha May 13, 2024 @ 1:10 PM Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Es... Source: Zacks Equity Research May 7, 2024 @ 9:10 PM Quanterix Corporation (QTRX) Reports Q1 Loss, Tops... Source: Zacks Equity Research Apr 30, 2024 @ 8:05 PM Exagen to Announce First Quarter 2024 Results on M... Source: Exagen Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.89 $-.21 $-.2 Diluted EPS $-.89 $-.21 $-.2 Revenue $ 58.86M $ 17.2M $ 15.5M Gross Profit $ 34.98M $ 10.4M $ 9.12M Net Income / Loss $ -16.98M $ -4.44M $ -3.75M Operating Income / Loss $ -14.04M $ -2.63M $ -3.37M Cost of Revenue $ 23.89M $ 6.81M $ 6.38M Net Cash Flow $ 5.55M $ 18.84M $ -10.84M PE Ratio